Pharmacological inhibition of ubiquitination sensitizes to DNA damaging agents by preventing homologous recombination repair

被引：0
|
作者：
Awasthi, Sharad
Yi, S. Stephen
McGrail, Daniel J.
Sahni, Nidhi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB043
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Oncometabolites suppress homologous recombination DNA repair by inhibition of chromatin remodeling at the DNA double-strand break
    Sulkowski, Parker S.
    Oeck, Sebstian
    Li, Jing
    Shuch, Brian
    King, Megan C.
    Bindra, Ranjit S.
    Glazer, Peter M.
    CANCER RESEARCH, 2019, 79 (13)
  • [32] DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
    de Almeida, Larissa Costa
    Calil, Felipe Antunes
    Machado-Neto, Joao Agostinho
    Costa-Lotufo, Leticia Veras
    CANCER GENETICS, 2021, 252 : 6 - 24
  • [33] Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination
    Daddacha, Waaqo
    Monroe, Dominique
    Carver, Kristen
    Usoro, Edidiong R.
    Alptekin, Ahmet
    Xu, Hongyan
    Osuka, Satoru
    Arbab, Ali S.
    Sakamuro, Daitoku
    CANCERS, 2022, 14 (18)
  • [34] Inhibition of Homologous Recombination and the DNA damage Checkpoint by Caffeine
    Tsabar, Michael
    Eapen, Vinay
    Memisoglu, Gonen
    Haber, James E.
    FASEB JOURNAL, 2013, 27
  • [35] PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations
    von Werdt, Alexander
    Brandt, Laura
    Scharer, Orlando D.
    Rubin, Mark A.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1639 - 1649
  • [36] Knockdown of NRAGE Impairs Homologous Recombination Repair and Sensitizes Hepatoblastoma Cells to Ionizing Radiation
    Liu, Li
    Cui, Zhongqi
    Zhang, Jie
    Wang, Jing
    Gu, Song
    Ma, Ji
    Chen, Hao
    Hang, Liang
    Yang, Jin
    Shi, Yi
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (01) : 41 - 49
  • [37] DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
    Graham, Laura
    Green, Edward
    Park, Joseph J.
    Kellezi, Olesia
    Hwang, Clara
    Barata, Pedro C.
    Bilen, Mehmet Asim
    Kilari, Deepak
    Clingerman, Melissa
    Tripathi, Abhishek
    Labriola, Matthew
    Rothstein, Shoshana
    Garje, Rohan
    Koshkin, Vadim S.
    Patel, Vaibhav G.
    Dorff, Tanya B.
    Armstrong, Andrew J.
    Mckay, Rana R.
    Alva, Ajjai Shivaram
    Schweizer, Michael Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [38] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Broustas, Constantinos G.
    Duval, Axel J.
    Chaudhary, Kunal R.
    Friedman, Richard A.
    Virk, Renu K.
    Lieberman, Howard B.
    ONCOGENE, 2020, 39 (12) : 2467 - 2477
  • [39] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Constantinos G. Broustas
    Axel J. Duval
    Kunal R. Chaudhary
    Richard A. Friedman
    Renu K. Virk
    Howard B. Lieberman
    Oncogene, 2020, 39 : 2467 - 2477
  • [40] Pharmacological inhibition of EZH2 combined with DNA-damaging agents interferes with the DNA damage response in MM cells
    Xu, Li
    Tang, Hailong
    Wang, Kai
    Zheng, Yanhua
    Feng, Juan
    Dong, Hongjuan
    Jin, Yulong
    Cao, Chun
    Chen, Xiequn
    Gao, Guangxun
    MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 4249 - 4255
12345